CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 392 of 1
Non-Antibody Products
Page 392 of 1,297
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| DL-Homocystine | An oxidized dimeric form of homocysteine; inhibits CDNB-induced L-cystine… | 25 g | 36223-25 | More Info |
| DL-Homocystine | An oxidized dimeric form of homocysteine; inhibits CDNB-induced L-cystine… | 5 g | 36223-5 | More Info |
| DL-4662 (hydrochloride) | A 3,4-dimethoxy derivative of the substituted cathinones: pentedrone and &… | 10 mg | 9002077-10 | More Info |
| DL-4662 (hydrochloride) | A 3,4-dimethoxy derivative of the substituted cathinones: pentedrone and &… | 5 mg | 9002077-5 | More Info |
| DL-4662 (hydrochloride) | A 3,4-dimethoxy derivative of the substituted cathinones: pentedrone and &… | 50 mg | 9002077-50 | More Info |
| DLin-DMA | An ionizable amino lipid; has been used in combination with other lipids i… | 10 mg | 36701-10 | More Info |
| DLin-DMA | An ionizable amino lipid; has been used in combination with other lipids i… | 100 mg | 36701-100 | More Info |
| DLin-DMA | An ionizable amino lipid; has been used in combination with other lipids i… | 25 mg | 36701-25 | More Info |
| DLin-DMA | An ionizable amino lipid; has been used in combination with other lipids i… | 250 mg | 36701-250 | More Info |
| DLin-KC2-DMA | An ionizable cationic amino lipid (apparent pKa = 6.7); administration of… | 1 mg | 34363-1 | More Info |
| DLin-KC2-DMA | An ionizable cationic amino lipid (apparent pKa = 6.7); administration of… | 10 mg | 34363-10 | More Info |
| DLin-KC2-DMA | An ionizable cationic amino lipid (apparent pKa = 6.7); administration of… | 25 mg | 34363-25 | More Info |
| DLin-KC2-DMA | An ionizable cationic amino lipid (apparent pKa = 6.7); administration of… | 5 mg | 34363-5 | More Info |
| DLin-MC2-DMA | An ionizable cationic lipid; has been used in the formation of LNPs; LNPs… | 1 mg | 39731-1 | More Info |
| DLin-MC2-DMA | An ionizable cationic lipid; has been used in the formation of LNPs; LNPs… | 10 mg | 39731-10 | More Info |
| DLin-MC2-DMA | An ionizable cationic lipid; has been used in the formation of LNPs; LNPs… | 25 mg | 39731-25 | More Info |
| DLin-MC2-DMA | An ionizable cationic lipid; has been used in the formation of LNPs; LNPs… | 5 mg | 39731-5 | More Info |
| DLin-MC3-DMA | An ionizable cationic amino lipid (apparent pKa = 6.44); administration of… | 1 mg | 34364-1 | More Info |
| DLin-MC3-DMA | An ionizable cationic amino lipid (apparent pKa = 6.44); administration of… | 10 mg | 34364-10 | More Info |
| DLin-MC3-DMA | An ionizable cationic amino lipid (apparent pKa = 6.44); administration of… | 25 mg | 34364-25 | More Info |
| DLin-MC3-DMA | An ionizable cationic amino lipid (apparent pKa = 6.44); administration of… | 5 mg | 34364-5 | More Info |
| DLin-MC4-DMA | An ionizable cationic lipid (pKa = 6.93); LNPs containing DLin-MC4-DMA and… | 1 mg | 39732-1 | More Info |
| DLin-MC4-DMA | An ionizable cationic lipid (pKa = 6.93); LNPs containing DLin-MC4-DMA and… | 10 mg | 39732-10 | More Info |
| DLin-MC4-DMA | An ionizable cationic lipid (pKa = 6.93); LNPs containing DLin-MC4-DMA and… | 25 mg | 39732-25 | More Info |
| DLin-MC4-DMA | An ionizable cationic lipid (pKa = 6.93); LNPs containing DLin-MC4-DMA and… | 5 mg | 39732-5 | More Info |
| DL-Isoleucine-d10 | An internal standard for the quantification of isoleucine by GC- or LC-MS | 1 mg | 34842-1 | More Info |
| DL-Isoleucine-d10 | An internal standard for the quantification of isoleucine by GC- or LC-MS | 10 mg | 34842-10 | More Info |
| DL-Isoleucine-d10 | An internal standard for the quantification of isoleucine by GC- or LC-MS | 25 mg | 34842-25 | More Info |
| DL-Isoleucine-d10 | An internal standard for the quantification of isoleucine by GC- or LC-MS | 5 mg | 34842-5 | More Info |
| DL-Malic Acid | The racemate of L-malic acid; reduces IFN-γ and TNF-α-induced… | 100 g | 33310-100 | More Info |
| DL-Malic Acid | The racemate of L-malic acid; reduces IFN-γ and TNF-α-induced… | 250 g | 33310-250 | More Info |
| DL-Malic Acid | The racemate of L-malic acid; reduces IFN-γ and TNF-α-induced… | 50 g | 33310-50 | More Info |
| DL-Mevalonolactone | A precursor in the mevalonate pathway; induces depolarization and swelling… | 1 g | 20348-1 | More Info |
| DL-Mevalonolactone | A precursor in the mevalonate pathway; induces depolarization and swelling… | 250 mg | 20348-250 | More Info |
| DL-Mevalonolactone | A precursor in the mevalonate pathway; induces depolarization and swelling… | 500 mg | 20348-500 | More Info |
| DL-3-n-Butylphthalide | A phthalide with diverse biological activities; inhibits ADP-, thrombin-,… | 1 g | 30284-1 | More Info |
| DL-3-n-Butylphthalide | A phthalide with diverse biological activities; inhibits ADP-, thrombin-,… | 5 g | 30284-5 | More Info |
| DL-3-n-Butylphthalide | A phthalide with diverse biological activities; inhibits ADP-, thrombin-,… | 500 mg | 30284-500 | More Info |
| DL-Norephedrine (hydrochloride) | A psychoactive amphetamine that acts as a potent norepinephrine releasing… | 10 mg | 14212-10 | More Info |
| DL-Norephedrine (hydrochloride) | A psychoactive amphetamine that acts as a potent norepinephrine releasing… | 100 mg | 14212-100 | More Info |
| DL-Norephedrine (hydrochloride) | A psychoactive amphetamine that acts as a potent norepinephrine releasing… | 50 mg | 14212-50 | More Info |
| DL-o-Tyrosine | A phenylalanine hydroxylation product; has been used as a marker of irradi… | 100 mg | 33570-100 | More Info |
| DL-o-Tyrosine | A phenylalanine hydroxylation product; has been used as a marker of irradi… | 250 mg | 33570-250 | More Info |
| DL-o-Tyrosine | A phenylalanine hydroxylation product; has been used as a marker of irradi… | 500 mg | 33570-500 | More Info |
| DL-Phenyl-d5-alanine | An internal standard for the quantification of DL-phenylalanine by GC- or… | 1 g | 34845-1 | More Info |
| DL-Phenyl-d5-alanine | An internal standard for the quantification of DL-phenylalanine by GC- or… | 100 mg | 34845-100 | More Info |
| DL-Propargyl Glycine (hydrochloride) | An irreversible inhibitor of H2S synthesis; blocks H2S synthesis activity… | 1 mg | 10010948-1 | More Info |
| DL-Propargyl Glycine (hydrochloride) | An irreversible inhibitor of H2S synthesis; blocks H2S synthesis activity… | 10 mg | 10010948-10 | More Info |
| DL-Propargyl Glycine (hydrochloride) | An irreversible inhibitor of H2S synthesis; blocks H2S synthesis activity… | 5 mg | 10010948-5 | More Info |
| DL-Propargyl Glycine (hydrochloride) | An irreversible inhibitor of H2S synthesis; blocks H2S synthesis activity… | 50 mg | 10010948-50 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile